Endothelial Dysfunction Hypercholesterolemia - PowerPoint PPT Presentation

1 / 5
About This Presentation
Title:

Endothelial Dysfunction Hypercholesterolemia

Description:

23 patients undergoing PTCA assigned to lovastatin 40 mg/day vs placebo ... to acetylcholine was noted in the lovastatin group at 51/2 months (LDL reduced ... – PowerPoint PPT presentation

Number of Views:90
Avg rating:3.0/5.0
Slides: 6
Provided by: kevinbob
Category:

less

Transcript and Presenter's Notes

Title: Endothelial Dysfunction Hypercholesterolemia


1
Endothelial Dysfunction - Hypercholesterolemia
Zeiher, A., et. al., Modulation of Coronary
Vasomotor Tone in Humans Progressive Endothelial
Dysfunction with Early Stages of Coronary
Atherosclerosis, Circulation, 1991 83 391-401
Pepine, C., et. al., Vascular Health as as
Therapeutic Target in Cardiovascular Disease,
Vascular Biology Working Group, University of
Florida, 1998.
  • A progressive impairment in endothelium-mediated
    modulation of coronary vasomotor tone exists with
    different stages of early atherosclerosis in
    humans
  • Patients with angiographically normal coronary
    arteries but with hypercholesterolemia and
    elevated plasma concentrations of LDL demonstrate
    a selective endothelial dysfunction with
    vasoconstriction in response to acetylcholine but
    preserved vasodilation in response to sympathetic
    stimulation and increased coronary blood flow
  • Angiographically normal coronary artery segments
    in patients with atherosclerosis elsewhere in the
    coronary system lose the ability to dilate in
    response to acetylcholine and sympathetic
    stimulation, whereas their ability to dilate flow
    dependently is still intact
  • Atherosclerotic vessels demonstrate a complete
    lack of vasoactive function

2
Endothelial Dysfunction - Hypercholesterolemia
  • Endothelium-dependent vasodilation is reduced in
    hypercholesterolemic human epicardial coronary
    and resistance vessels
  • There is a progressive impairment in
    endothelium-mediated modulation of coronary
    vasomotor tone with different stages of early
    atherosclerosis in humans
  • These abnormalities likely contribute to angina
    during exertion or emotional stress
  • Indeed, human coronary arteries exhibiting an
    abnormal response to acetylcholine also
    vasoconstrict with mental stress, exertion, or in
    response to the cold pressor test, according to
    previous studies

Pepine, C., et. al., Vascular Health as as
Therapeutic Target in Cardiovascular Disease,
Vascular Biology Working Group, University of
Florida, 1998.
3
Cholesterol-Lowering Endothelial Function
  • Randomized, double-blind study to evaluate
    HMGCoA-R rx.
  • 23 patients undergoing PTCA assigned to
    lovastatin 40 mg/day vs placebo
  • Intracoronary infusion of acetylcholine at 12
    days and 51/2 months
  • Significant improvement in response to
    acetylcholine was noted in the lovastatin group
    at 51/2 months (LDL reduced from 148/-7 to
    110/-8)

Treasure, C., et. al., Beneficial Effects of
Cholesterol-Lowering Therapy on the Coronary
Endothelium in Patients with Coronary Artery
Disease, NEJM, vol. 332, no. 8, February 23,
1995, pp. 481-487.
4
eNOS Ischemic Stroke
  • Few therapeutic options are available for
    preventing or treating ischemic stroke
    prophylactic treatment strategies are limited
    mainly to agents that block platelet aggregation
    or the coagulation cascade
  • Clinical trials have demonstrated the
    effectiveness of anti-platelet agents in reducing
    the incidence of ischemic stroke, but it is not
    clear whether they impact on cerebral infarct
    size
  • In mice, increased NO production achieved by
    infusing L-arginine, the substrate for NO
    synthesis, decreases cerebral ischemia and limits
    cerebral infarct size

Liao, J., Nitric Oxide and Cardiovascular
Disease, Card.iology Rounds (Brigham Womens
Hospital), vol. 2, issue 5 (5/98).
5
eNOS Ischemic Stroke
Liao, J., Nitric Oxide and Cardiovascular
Disease, Card.iology Rounds (Brigham Womens
Hospital), vol. 2, issue 5 (5/98).
  • In an experimental model using eNOS-deficient
    mice, following middle cerebral artery occlusion,
    larger strokes are noted as compared with
    wild-type mice who are similarly treated
  • Recent studies have demonstrated that treatment
    with statins upregulates eNOS mRNA expression and
    enzyme activity even in mice who are
    normocholesterolemic
  • This upregulation of eNOS by statins was
    independent of serum cholesterol levels and
    caused both increased cerebral blood flow and
    smaller cerebral infarcts following experimental
    middle cerebral artery occlusion
Write a Comment
User Comments (0)
About PowerShow.com